What is Pearl Pathways?
Pearl Pathways operates as a comprehensive professional services firm dedicated to accelerating the development of life-saving therapeutics, devices, and diagnostics. The company offers specialized support across regulatory strategy, quality compliance, and clinical services. Its client base includes biopharmaceutical, medical device, and diagnostic companies, as well as life science service providers. By leveraging an experienced team, Pearl Pathways assists clients in navigating complex regulatory landscapes and achieving successful product development, including the provision of a full-service central Institutional Review Board (IRB) for human research support.
How much funding has Pearl Pathways raised?
Pearl Pathways has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pearl Pathways
PPP
Public-Private Partnership
What's next for Pearl Pathways?
The substantial backing and strategic investment indicate Pearl Pathways is in a significant growth phase, likely focusing on scaling its operations and expanding its service offerings. This capital infusion is expected to bolster its capabilities in regulatory affairs, quality assurance, and clinical trial management, further solidifying its role as a key partner for life science innovators seeking to bring novel products to market. The company's focus on late-stage funding suggests a mature operational model poised for accelerated market penetration and potential strategic acquisitions or partnerships.
See full Pearl Pathways company page
